Jump Financial, LLC Vericel Corp Transaction History

Jump Financial, LLC

$4.56 Billion
Q3 2024

A detailed history of Jump Financial, LLC transactions in Vericel Corp stock. As of the latest transaction made, Jump Financial, LLC holds 13,145 shares of VCEL stock, worth $739,406. This represents 0.01% of its overall portfolio holdings.

Number of Shares

13,145

Holding current value

$739,406

% of portfolio

0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$42.25 - $53.56 $555,376 - $704,046	13,145 New	13,145 $555,000
Q4 2023 Oct 21, 2024	SELL	$30.85 - $37.09 $1.44 Million - $1.73 Million	-46,667 Reduced 88.73%	5,927 $211,000
Q4 2023 Feb 07, 2024	SELL	$30.85 - $37.09 $1.44 Million - $1.73 Million	-46,667 Reduced 88.73%	5,927 $211,000
Q3 2023 Oct 21, 2024	BUY	$31.69 - $39.25 $368,649 - $456,595	11,633 Added 28.4%	52,594 $1.76 Million
Q3 2023 Nov 07, 2023	BUY	$31.69 - $39.25 $368,649 - $456,595	11,633 Added 28.4%	52,594 $1.76 Million
Q2 2023 Oct 21, 2024	BUY	$29.0 - $38.37 $981,969 - $1.3 Million	33,861 Added 476.92%	40,961 $1.54 Million
Q2 2023 Aug 07, 2023	BUY	$29.0 - $38.37 $981,969 - $1.3 Million	33,861 Added 476.92%	40,961 $1.54 Million
Q1 2023 Oct 21, 2024	BUY	$23.85 - $31.34 $169,335 - $222,514	7,100 New	7,100 $208,000
Q1 2023 May 03, 2023	SELL	$23.85 - $31.34 $574,689 - $755,168	-24,096 Reduced 77.24%	7,100 $208,000
Q4 2022 Feb 13, 2023	SELL	$17.65 - $27.37 $35,370 - $54,849	-2,004 Reduced 6.04%	31,196 $821,000
Q3 2022 Nov 07, 2022	SELL	$22.62 - $32.54 $280,940 - $404,146	-12,420 Reduced 27.22%	33,200 $770,000
Q2 2022 Aug 09, 2022	BUY	$22.88 - $39.45 $1.04 Million - $1.8 Million	45,620 New	45,620 $1.15 Million
Q4 2021 Feb 10, 2022	SELL	$35.2 - $52.6 $173,571 - $259,370	-4,931 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$46.35 - $59.75 $228,551 - $294,627	4,931 New	4,931 $241,000

Others Institutions Holding VCEL

# of Institutions

277

Shares Held

48.8M

Call Options Held

91.8K

Put Options Held

23.2K

View Full List

About Vericel Corp

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.65B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

More about VCEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.

Account